Major bleeding risk and mortality associated with antiplatelet drugs in real-world clinical practice. A prospective cohort study

BACKGROUND: Major bleedings other than gastrointestinal (GI) and intracranial (ICH) and mortality rates associated with antiplatelet drugs in real-world clinical practice are unknown. The objective was to estimate major bleeding risk and mortality among new users of antiplatelet drugs in real-world...

Descripción completa

Detalles Bibliográficos
Autores principales: Bouget, Jacques, Balusson, Frédéric, Viglino, Damien, Roy, Pierre-Marie, Lacut, Karine, Pavageau, Laure, Oger, Emmanuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7413418/
https://www.ncbi.nlm.nih.gov/pubmed/32764775
http://dx.doi.org/10.1371/journal.pone.0237022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7413418/
https://www.ncbi.nlm.nih.gov/pubmed/32764775
http://dx.doi.org/10.1371/journal.pone.0237022

Ejemplares similares